$UAMY

UNITED STATES ANTIMONY CORP

No enriched coverage for $UAMY in the last 7 days.

No SEC Form 4 filings for $UAMY in the last 30 days.

See all $UAMY insider activity →

Texas Capital Securities initiates US Antimony stock with buy rating

Texas Capital Securities initiated coverage on US Antimony (UAMY) with a Buy rating and $9.50 price target, citing its vertical integration strategy and defense contracts. The stock trades near its 52-week low at $3.86. The company reported Q2 revenue of $7.9M, down 25% YoY, and adjusted full-year guidance to $60M-$75M. It also approved a $100M share repurchase program.

UNITED STATES ANTIMONY CORP (UAMY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

UNITED STATES ANTIMONY CORP (UAMY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 1, 2026, United States Antimony Corporation (the “Company”) entered into an employment agreement with Gary C. E

UAMY sentiment & insider activity

Recent UAMY coverage spans financial news, insider activity and corporate actions.

What's driving UAMY

AlphAI scores every news story that mentions UAMY with an AI model for sentiment and relevance, and aggregates insider trades from UNITED STATES ANTIMONY CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $UAMY

Score
$UAMYHighAI 8/10

Texas Capital Securities initiates US Antimony stock with buy rating

Texas Capital Securities initiated coverage on US Antimony (UAMY) with a Buy rating and $9.50 price target, citing its vertical integration strategy and defense contracts. The stock trades near its 52-week low at $3.86. The company reported Q2 revenue of $7.9M, down 25% YoY, and adjusted full-year guidance to $60M-$75M. It also approved a $100M share repurchase program.

UNITED STATES ANTIMONY CORP (UAMY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

UNITED STATES ANTIMONY CORP (UAMY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 1, 2026, United States Antimony Corporation (the “Company”) entered into an employment agreement with Gary C. E

UNITED STATES ANTIMONY CORP (UAMY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

UNITED STATES ANTIMONY CORP (UAMY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Chief Financial Officer Transition As previously reported, on May 4, 2026, Shawn P. Winkler was appointed as the Interim C

Top insider buys and sells disclosed on Wednesday

Nvidia plans to acquire AI platform Hugging Face for $12.9B. Insider trading activity included significant buys and sells in companies like Donegal Group (DGICA), Hanover Bancorp (HNVR), Pinnacle Financial (PNFP), and Synopsys (SNPS). Notable transactions involved executives and major shareholders, with some stocks appearing undervalued or overvalued according to InvestingPro analysis.

$OPTULow

Top insider buys and sells from Friday’s market activity

On August 28, 2026, notable insider trading included Optimum Communications (OPTU) director Neil S. Subin buying $2.45M in shares, REGENXBIO (RGNX) director Gregory Austin Ciongoli purchasing $949K, and Pulse Biosciences (PLSE) COO Liane Rae Teplitsky acquiring $99K. United States Antimony (UAMY) CEO Gary C. Evans bought $98K in shares, while Battalion Oil (BATL) director William D. Rogers purchased $91K. On the sell side, Life Time Group (LTH) insiders sold $126M, Relay Therapeutics (RLAY) 10%

$UAMYLow

United States Antimony Corp (UAMY) Chairman & CEO Gary Evans Buy

United States Antimony Corp (UAMY) CEO Gary Evans bought 20,000 shares at $4.92 each, increasing his stake to 2.59M shares. Over the past year, Evans has bought 120,000 shares with no sales, indicating confidence in the company's prospects. UAMY's market cap is $725.897M, trading at a 20% premium to its GF Value of $4.11, suggesting modest overvaluation.

Related tickers